Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for sedation during routine gastroscopy
ChiCTR2000038694Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in None comparing Remimazolam + propofol, Propofol and Remimazolam (3 arms). Primary endpoints: Sedation success rate, Effect on sleep status and 2 more. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2000038694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038694.